Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors |
Baylor College of Medicine / Andras Heczey, MD |
R Accelerated Award Grants |
2023 |
Texas |
Identifying Therapeutic Vulnerabilities in Pediatric AML through Investigation of the MECOM Transcriptional Network |
Boston Children’s Hospital / Richard Voit, MD/PhD |
Young Investigator Grants |
2023 |
Massachusetts |
CLL-1 CAR-T cells with or without trametinib for the treatment of JMML |
The Regents of the University of California San Francisco / Elliot Stieglitz, MD |
R Accelerated Award Grants |
2023 |
California |
Creating an Infrastructure for Collaborative Clinical Research and Publication of Consensus Guidelines for RUNX1 Familial Platelet Disorder |
The Cleveland Clinic Foundation / Brittany Stewart, PhD |
RUNX1 Early Career Investigator Grants |
2023 |
Ohio |
Activation of Anti-Leukemia Immunity by Targeting Protein Arginine Methyltransferase |
City of Hope National Medical Center / Ling Li, PhD |
R Accelerated Award Grants |
2023 |
California |
Empowering specificity of AML immunotherapies by HSC engineering |
Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Pietro Genovese |
Catalyst Grants |
2023 |
Georgia |
Immunoglobulin High-Throughput Sequencing for Refining Risk Stratification in Infant B-ALL |
University of Rochester / Carol Fries Simpson, MD |
Reach Grants |
2023 |
New York |
Identification of Aberrantly Methylated Differentially Expressed Genes to Distinguish High- vs. Low-Risk Retinoblastoma |
Children’s Hospital Los Angeles / Jesse Berry, MD |
Reach Grants |
2023 |
California |
Mechanisms to Redirect Tumor Associated Macrophages to Target Retinoblastoma Cells |
The Regents of the University of Minnesota / Timothy Hallstrom, PhD |
Innovation Grants |
2023 |
Minnesota |
Targeting Chromatin Remodeling Complexes for Rhabdomyosarcoma (RMS) Therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2023 |
Massachusetts |